Can a pill rouse the immune system against pancreatic cancer?

This early-phase trial is testing whether an experimental oral drug called BXCL701 can change how the immune system responds to pancreatic cancer. The study will enroll people with untreated, locally advanced or metastatic pancreatic cancer who can undergo tumor biopsies before and after treatment. Researchers will measure immune markers in the blood and tumor, and check whether the drug affects tumor growth or cell death. The goal is to see if this approach is worth studying further.